These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Interaction of ORG 10172, a low molecular weight heparinoid, and digoxin in healthy volunteers. de Boer A; Stiekema JC; Danhof M; Moolenaar AJ; Breimer DD Eur J Clin Pharmacol; 1991; 41(3):245-50. PubMed ID: 1748141 [TBL] [Abstract][Full Text] [Related]
23. The pharmacokinetics of LMW dermatan sulphate: long-term persistence of intact material. Dawes J Thromb Haemost; 1993 Apr; 69(4):339-43. PubMed ID: 8497846 [TBL] [Abstract][Full Text] [Related]
24. The pharmacokinetics of dermatan sulphate MF701 in healthy human volunteers. Dawes J; McLaren M; Forbes C; Belch JJ; Lane DA; Bray B; McEwen J; Houin G; Gianese F Br J Clin Pharmacol; 1991 Sep; 32(3):361-6. PubMed ID: 1777373 [TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and pharmacodynamics of dermatan sulfate after intravenous and intramuscular administration to healthy volunteers. Blardi P; Messa GL; Urso R; Di Perri T Int J Clin Pharmacol Res; 1993; 13(4):231-8. PubMed ID: 8150550 [TBL] [Abstract][Full Text] [Related]
26. Studies of interaction of a low-molecular-weight heparinoid (Org 10172) with cloxacillin and ticarcillin in healthy male volunteers. de Boer A; Stiekema JC; Danhof M; van Dinther TG; Boeijinga JK; Cohen AF; Breimer DD Antimicrob Agents Chemother; 1991 Oct; 35(10):2110-5. PubMed ID: 1759835 [TBL] [Abstract][Full Text] [Related]
31. ORG 10172: a low molecular weight heparinoid anticoagulant with a long half-life in man. Bradbrook ID; Magnani HN; Moelker HC; Morrison PJ; Robinson J; Rogers HJ; Spector RG; Van Dinther T; Wijnand H Br J Clin Pharmacol; 1987 Jun; 23(6):667-75. PubMed ID: 3606928 [TBL] [Abstract][Full Text] [Related]
32. Evidence for antithrombin III involvement in the anticoagulant activity of cellulose sulphate. Kindness G; Long WF; Williamson FB Br J Pharmacol; 1980 Apr; 68(4):645-9. PubMed ID: 7378640 [TBL] [Abstract][Full Text] [Related]
33. Anticoagulant effects of a low molecular weight heparinoid (Org 10172) in human volunteers and haemodialysis patients. ten Cate H; Henny CP; ten Cate JW; Büller HR; Mooy MC; Surachno S; Wilmink JM Thromb Res; 1985 Jul; 39(2):211-22. PubMed ID: 3161213 [TBL] [Abstract][Full Text] [Related]
34. Anticoagulant activity of a dermatan sulfate from the skin of the shark Scyliorhinus canicula. Dhahri M; Mansour MB; Bertholon I; Ollivier V; Boughattas NA; Hassine M; Jandrot-Perrus M; Chaubet F; Maaroufi RM Blood Coagul Fibrinolysis; 2010 Sep; 21(6):547-57. PubMed ID: 20581662 [TBL] [Abstract][Full Text] [Related]
35. Effect of dermatan sulphate on activated partial thromboplastin time determined with different reagents. Iorio A; Nucciarelli F; Renga C; Nenci GG; Gianese F; Agnelli G Haemostasis; 1997; 27(2):85-90. PubMed ID: 9212356 [TBL] [Abstract][Full Text] [Related]
36. Heparin cofactor II and other endogenous factors in the mediation of the antithrombotic and anticoagulant effects of heparin and dermatan sulfate. Ofosu FA; Fernandez F; Gauthier D; Buchanan MR Semin Thromb Hemost; 1985 Apr; 11(2):133-7. PubMed ID: 3898370 [No Abstract] [Full Text] [Related]
37. Pharmacokinetics of low molecular weight dermatan sulphate (desmin) in different cohorts of patients. Saivin S; Carrie D; Escourrou J; Duchene P; Zamboni V; Barbanti M; Palazzini E; Houin G Thromb Res; 1998 May; 90(3):139-45. PubMed ID: 9684733 [No Abstract] [Full Text] [Related]
38. The pharmacokinetics and pharmacodynamics of dermatan sulphate MF701 during haemodialysis for chronic renal failure. Gianese F; Nurmohamed MT; Imbimbo BP; Büller HR; Berckmans RJ; Ten Cate JW Br J Clin Pharmacol; 1993 Mar; 35(3):335-9. PubMed ID: 8471416 [TBL] [Abstract][Full Text] [Related]
39. Pharmacologic properties of a low molecular weight dermatan sulfate: comparison with unfractionated dermatan sulfate. Dol F; Petitou M; Lormeau JC; Choay J; Caranobe C; Sie P; Saivin S; Houin G; Boneu B J Lab Clin Med; 1990 Jan; 115(1):43-51. PubMed ID: 2299256 [TBL] [Abstract][Full Text] [Related]
40. Partial in vivo neutralisation of plasma anticoagulant effects of Lomoparan (Org 10172) by protamine chloride. Stiekema JC; Wijnand HP; ten Cate H; ten Cate JW; Harenberg J; Egberts JF; van Dinther TG Thromb Res; 1991 Jul; 63(1):157-67. PubMed ID: 1948817 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]